Posted by Michael Wonder on 21 Aug 2018
Trump administration says its drug blueprint has already lowered prices
20 August 2018 - The Trump administration claims the president’s blueprint to tackle high drug prices is already sparking a “sea change” that's prompting pharmaceutical companies to lower prices.
Since Trump outlined the blueprint in May, there have been 60% fewer price hikes for brand name drugs compared to the same period in 2017, the administration said in a report released Monday 100 days after it was released. There have also been 54% more generic and brand drug price decreases compared to the same period in 2017.
Administration officials declined to say that the price changes were solely due to the blueprint, but hinted the changes are the beginning of a greater shift among pharma companies on prices.
